Clinical Trials Directory

Trials / Completed

CompletedNCT06949072

A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries

A Randomized, Single-Blind, Cross-Over Clinical Study to Assess an Experimental Dentifrice in an in Situ Model of Early Stage Caries

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the relative efficacy of an experimental dentifrice containing 1150 parts per million (ppm) fluoride (as sodium fluoride \[NaF\]) to remineralize early stage caries type lesions in an in situ model compared to a negative control and a reference dentifrice.

Detailed description

This is a randomized, single-blind, single-center, controlled, three period, three treatment, cross-over caries in situ model in healthy participants who wear a suitable removable mandibular partial denture. The denture will be modified to accommodate 2 gauze-covered, 4 millimeter (mm) round specimens of bovine dental enamel that have been previously demineralized in vitro to form artificial caries lesions. After 14 days of twice daily product use off-site, the specimens will be removed at the study site to determine the remineralization ability of the treatments. The same procedure will be followed for period 2 and 3 with a washout period of 2-3 days prior to each treatment period. Sufficient participants will be screened to randomize up to 50 participants to the study.

Conditions

Interventions

TypeNameDescription
DRUGTest DentifriceDentifrice containing 5 percent (%) weight by weight (w/w) Potassium nitrate (KNO3) and 1150ppm fluoride as sodium fluoride.
DRUGReference DentifriceDentifrice containing 1100ppm fluoride as stannous fluoride.
DRUGNegative Control DentifriceDentifrice containing 5% KNO3 with no fluoride.

Timeline

Start date
2025-04-28
Primary completion
2025-09-11
Completion
2025-09-11
First posted
2025-04-29
Last updated
2025-09-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06949072. Inclusion in this directory is not an endorsement.